retatrutide weight loss trials results Lilly's triple agonist achieves 16.8% in phase 3 trial Retatrutide Phase 3: TRIUMPH Program

This ensures that your fat loss is optimized, and you are achieving your health goals safely

Wegovy is FDA-approved for long-term weight management in adults who are fat or overweight and who suffer from at least one weight-related illness, such as type 2 diabetes, high blood pressure, or high cholesterol

It can alleviate the burden on the liver and other detoxification organs, leading to better overall health and improved organ function

This helps maintain a steady level of the medication in your system

While once-weekly injectable formulations improve convenience, the need for subcutaneous administration remains a barrier for some patients